Sintilimab Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma

Condition:   Nasopharyngeal Neoplasms
Interventions:   Drug: Sintilimab;   Drug: Gemcitabine;   Drug: Cisplatin;   Radiation: intensity-modulated radiotherapy
Sponsors:   Sun Yat-sen University;   Innovent Biologics (Suzhou) Co. Ltd.
Not yet recruiting

https://ift.tt/2MuLKwj